Press Releases
Press Releases
Provepharm¹s Japanese partner Daiichi Sankyo files an NDA to market the Methylene Blue injection medicinal product in Japan
Provepharm, a French company specialized in the development of pharmaceutical applications announces that Daiichi Sankyo, Co. Ltd., a global pharmaceutical firm, has filed an NDA For the development and marketing of the injectable Methylene Blue medicinal...
Press Releases
CiToxLAB appoints John C. Kapeghian as senior director of toxicology in North America
This appointment makes the Montreal site attractive to North American clients and boosts CiToxLAB’s expertise in preclinical development and regulatory affairs. CiToxLAB, a leading CRO in the field of non-clinical research, announces today that John...
Press Releases
Adocia announces preliminary positive clinical results for its combination of long-acting insulin Glargine and fast-acting insulin analog Lispro, Biochaperone(R) Combo
Adocia’s BioChaperone Combo is the first product combining insulin Glargine with a fast-acting insulin analogPhase I/II clinical trial demonstrates proof of concept in patients with type 1 diabetes, showing that BioChaperone Combo acts faster and longer than Humalog Mix...
Press Releases
UBM to Launch Southeast Asia’s Leading International Beauty Trade Show In Thailand
BANGKOK Feb. 25 2014 - UBM Asia is pleased to announce the launch of ASEANbeauty the only beauty trade event supported by the Thai Cosmetics Manufacturers Association. This is to be the premier international beauty trade show for South...
Press Releases
The Most Complete Information on America’s Nursing Facilities
WASHINGTON: U.S. News & World Report publisher of Best Hospitals and Best Children's Hospitals today released its Best Nursing Homes 2014 highlighting the top nursing homes in every state and nearly 100 major metropolitan areas.
Now in its sixth year...
Press Releases
NBE-Therapeutics Announces Successful Validation of its SMAC™-Technology for the Generation of Antibody Drug Conjugates (ADCs)
Basel, Switzerland, February 21, 2014 - NBE-Therapeutics (“NBE”) today announced that it has presented the successful validation of its enzymatic SMAC™-Technology for the generation of potent next-generation antibody drug conjugates (ADCs) at the international World ADC summit 2014 in...
Press Releases
Domain Therapeutics enters into collaboration with XOMA
DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies Strasbourg, France, February 4, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read